Market Access Views & Analysis

Views & Analysis

Market Access

Reuters Europe 2025: Using value propositions to improve acc...

In a Reuters Pharma Europe 2025 fireside chat, NICE Advice Director Brad Grove spoke with Novartis's Matic Meglic about novel pharma payment models.

Market Access

Reuters Europe 2025: Trade-offs in European launch sequencin...

At Reuters, industry stakeholders discussed how, especially in light of the current tariff crisis, Europe must operate as a unit when pricing drugs.

Market Access

Reuters Europe 2025: Collaboration key for innovation, BI he...

At Reuters Pharma Europe, Francesco Di Marco of Boehringer Ingelheim focused on the importance of innovating together.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Market Access

Bridging research and clinical guidelines – interactive stra...

Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.

Market Access

5 ways to address pricing and access challenges across the E...

In the feature ‘Successfully navigating the complexity of market access across Europe to improve health equity’, originally published in the European Biopharmaceutical Review, EVERSANA Gene

Market Access

Boehringer US head covers GLP-1s, PBMs, Trump at Reuters USA

Brian Hilberdink, Boehringer Ingelheim's new Head of US Human Pharma, fielded questions on a variety of hot topics from the Reuters Pharma USA stage.

Reuters Europe 2025: Using value propositions to improve acc...

Reuters Europe 2025: Trade-offs in European launch sequencin...

Reuters Europe 2025: Collaboration key for innovation, BI he...

Bridging research and clinical guidelines – interactive stra...

5 ways to address pricing and access challenges across the E...

Boehringer US head covers GLP-1s, PBMs, Trump at Reuters USA

Trustworthy and novel AI in clinical trial planning, with Kr...

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks